Montivak® 5 mg

The International Nonproprietory Name: Montelukast
Indications for use:

Drugs for the treatment of obstructive respiratory diseases. Leukotriene receptor antagonists.

Motilac, chewable tablets 4 mg, are indicated for use in children aged 2 to 5 years.
  • Dosage and packaging
    5 mg №30
  • Scope of application
    Pulmonology
  • Form of vacation
    On prescription
  • Pharmacotherapeutic group
    Allergology